Company Capital Raisings
NOTE: The ATM capital raising event is an aggregate sum of transactions reported as of current date. The price is the weighted average price of total transactions.
| Company |
Ascendis Pharma A/S |
| Ticker Symbol |
ASND |
| CUSIP Number |
04351P101 (Active) |
| US ISIN |
US04351P1012 |
| Country |
Denmark |
| Security Type |
ADR |
| Listing Exchange |
NASDAQ |
| Ratio (ORD:DR) |
1 :1 |
| Date |
Shares # |
Price $ |
Value $ |
Event Type |
Lead Manager |
1st Co-Manager |
2nd Co-Manager |
Issuer's US Counsel |
Issuer's Local Counsel |
| 9/7/2021 |
2,500,000 |
160.00 |
400,000,000 |
Follow-On |
JP Morgan |
Morgan Stanley |
|
Latham & Watkins LLP |
Mazanti-Andersen |
| 7/10/2020 |
4,859,154 |
142.00 |
689,999,868 |
Follow-On |
JP Morgan |
Morgan Stanley |
|
Latham & Watkins LLP |
Mazanti-Andersen |
| 3/5/2019 |
4,791,667 |
120.00 |
575,000,040 |
Follow-On |
JP Morgan |
Morgan Stanley |
Credit Suisse |
Latham & Watkins LLP |
Mazanti-Andersen |
| 2/21/2018 |
4,539,473 |
57.00 |
258,749,961 |
Follow-On |
BofA Merrill Lynch |
Credit Suisse |
JP Morgan |
Latham & Watkins LLP |
Mazanti-Andersen |
| 9/29/2017 |
4,370,000 |
35.50 |
155,135,000 |
Follow-On |
JP Morgan |
|
|
|
|
| 10/19/2016 |
6,315,789 |
19.00 |
119,999,991 |
Follow-On |
JP Morgan |
BofA Merrill Lynch |
Credit Suisse |
|
|
| 1/27/2015 |
6,900,000 |
18.00 |
124,200,000 |
IPO |
BofA Merrill Lynch |
Leerink Partners |
Wells Fargo Securities |
Latham & Watkins LLP |
Mazanti-Andersen |
Click here to search Capital Raisings for other DR programs
NOTE: The ATM capital raising event is an aggregate sum of transactions reported as of current date. The price is the weighted average price of total transactions.
|